Esperion Therapeutics, Inc. (ESPR)
Jul 13, 2026 - ESPR was delisted
3.180
-0.010 (-0.31%)
Inactive · Last trade price on Jul 10, 2026
Esperion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7.42 | -22.68 | -51.75 | -209.25 | -233.66 | -269.11 |
Depreciation & Amortization | 0.11 | 0.11 | 0.06 | 0.16 | 0.5 | 0.61 |
Other Amortization | 2.9 | 3.01 | 1.5 | 1.7 | 1.62 | 1.62 |
Loss (Gain) From Sale of Investments | - | - | - | -0.41 | 0.28 | 0.01 |
Stock-Based Compensation | 9.91 | 9.87 | 11.99 | 11.96 | 15.22 | 24.31 |
Other Operating Activities | 4.05 | 11.25 | 75.07 | 46.68 | 44.59 | 31.26 |
Change in Accounts Receivable | -51.06 | -60.05 | -31.65 | -14.77 | -10.8 | -10.55 |
Change in Inventory | -4.89 | -10.63 | -28.87 | -30.42 | -0.81 | -18.26 |
Change in Accounts Payable | -3.59 | 20.92 | 12.43 | 8.68 | 5.6 | -34.1 |
Change in Unearned Revenue | 38.99 | 25.96 | -16.88 | 21.9 | -2.81 | 4.66 |
Change in Other Net Operating Assets | -7.18 | 9.16 | 4.44 | 28.29 | 5.44 | 5.74 |
Operating Cash Flow | -18.19 | -13.09 | -23.65 | -135.49 | -174.83 | -263.81 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.19 | - | -0.32 | - | - | - |
Investment in Securities | - | - | - | 42.5 | 8.1 | -50.48 |
Investing Cash Flow | -0.19 | - | -0.32 | 42.5 | 8.1 | -50.48 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 99.73 | - | - | - |
Long-Term Debt Repaid | - | -54.91 | -210.09 | - | - | - |
Net Debt Issued (Repaid) | -54.91 | -54.91 | -110.36 | - | - | - |
Issuance of Common Stock | 114.57 | 98.35 | 105.99 | 65.95 | 90.85 | 222.45 |
Repurchase of Common Stock | - | - | -343.75 | - | -50 | - |
Other Financing Activities | 0.24 | -7.26 | 434.6 | -15.49 | -8.24 | 45.77 |
Financing Cash Flow | 59.9 | 36.18 | 86.48 | 50.46 | 32.61 | 268.22 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 41.53 | 23.09 | 62.51 | -42.53 | -134.12 | -46.07 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -18.38 | -13.09 | -23.97 | -135.49 | -174.83 | -263.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -4.39% | -3.25% | -7.21% | -116.46% | -231.64% | -336.29% |
Free Cash Flow Per Share | -0.08 | -0.06 | -0.13 | -1.31 | -2.63 | -9.13 |
Levered Free Cash Flow | -49.71 | -52.59 | -65.72 | -129.64 | -135.56 | -192.19 |
Unlevered Free Cash Flow | 0.5 | -2.72 | -30.18 | -94.48 | -101.67 | -164.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | 5.83 | 15.51 | 8.02 | - |
Change in Working Capital | -27.73 | -14.64 | -60.53 | 13.68 | -3.37 | -52.51 |